G. E. Adams et al., "RSU1069, A 2-Nitroimidazole Containing an Alkylating Group: High Efficiency as a Radio-and Chemosensitizer in vitro and in vivo", Int. J. Radiation Oncology Biol. Phys., vol. 10, pp. 1653-1656 (1984). |
A. Albert et al., "The Ionisation of Acridine Bases", J. Chem. Soc., pp. 706-713 (1946). |
J. M. Brown et al., "SR-2508: A 2-Nitroimidazole Amide Which Should be Superior to Misonidazole as a Radiosensitizer for Clinical Usa", Int. J. Radiation Oncology Biol. Phys., vol. 7, pp. 695-703 (1981). |
N. S. Burres et al., "Antitumor Activity and Mechanism of Action of the Novel Marine Natural Products Mycalamide-A and -B and Onnamide", Cancer Research, 49, 2935-2940 (Jun. 1, 1989). |
D. S. M. Cowan et al., "Targeting Radiosensitizers to DNA by Attachtment of an Intercalating Group: Nitroimidazole-Linked Phenanthridines", Radiation Research, 127, pp. 81-89 (1991). |
M. F. Dennis et al., "Cellular uptake of misonidazole and analogues with acidic or basic functions", Int. J. Radiat. Biol., vol. 47, No. 6, pp. 629-643 (1985). |
W. A. Denny et al., "Interrelations between anti-tumour activity, DNA breakage, and DNA binding kinetics for 9-aminoacridinecarboxamide anti-tumour agents", Anti-Cancer Drug Design, 1, pp. 141-147 (1986). |
W. A. Denny et al., "NLA-1: A 2-Nitroimidazole Radiosensitizer Targeted to DNA by Intercalation", Int. J. Radiation Oncology Biol. Phys., vol. 22, pp. 553-556 (1992). |
W. A. Denny et al., "Hypoxia-Selective Antitumor Agents. 6. 4-(Alkylamino)nitroquinolines: A New Class of Hypoxia-Selective Cytotoxins", J. Med. Chem., 35, pp. 4832-4841 (1992). |
J. Feigon et al., "Interactions of Antitumor Drugs with Natural DNA: .sup.1 H NMR Study of Binding Mode and Kinetics", J. Med. Chem., 27, pp. 450-465 (1984). |
T. Fujita et al., "A New Substituent Constant, .pi., Derived from Partition Coefficients", J. Am. Chem. Soc., 86, pp. 5175-5180 (1964). |
C. Grau et al., "Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay", Radiotherapy and Oncology, 13, pp. 301-309 (1988). |
E. Hatzigrigoriou et al., "2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: A Novel Class of Radio-and Chemosensitizers of V79 Cells", Oncology Research, vol. 5, No. 1, pp. 29-36 (1993). |
K. A. Kennedy, "Hypoxic cells as specific drug targets for chemotherapy", Anti-Cancer Drug Design, 2, pp. 181-194 (1987). |
A. I. Minchinton et al., "A Comparison of Tumor and Normal Tissue Levels of Acidic Basic and Neutral 2-Nitroimidazole Radiosensitizers in Mice", Int. J. Radiation Oncology Biol. Phys., vol. 12, pp. 1117-1120 (1986). |
D. Murray et al., "Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo", Br. J. Cancer, 47, pp. 195-203 (1983). |
R. Panicucci et al., "NLP-1: A DNA Intercalating Hypoxic Cell Radiosensitizer and Cytotoxic", Int. J. Radiation Oncology Biol. Phys., vol. 16, pp. 1039-1043 (1989). |
M. V. Papadopoulou et al., "Radiosensitization and Hypoxic Cell Toxicity of NLA-1 and NLA-2, Two New Bioreductive Compounds", Jpn. J. Cancer Res., 83, pp. 410-414 (Apr. 1992). |
M. V. Papadopoulou et al., "Potentiation of 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea's Toxicity in vitro by Two New Bioreductive Agents," Jpn. J. Cancer Res., 83, pp. 907-913 (Aug. 1992). |
M. V. Papadopoulou et al., "Nitroheterocyclic-linked acridines as DNA-targeting bioreductive agents", Drugs of the Future, 18(3), pp. 231-238 (1993). |
M. V. Papadopoulou et al., "Potentiation of Antineoplastic Drugs In Vitro and In Vivo by DNA Intercalating Bioreductive Agents", Radiation Oncology Investigations, 1, pp. 206-217 (1993). |
K. Reszka et al., "Interaction of the Peroxidase-Derived Metabolite of Mitoxantrone with Nucleic Acids", Biochemical Pharmacology, vol. 38, No. 23, pp. 4253-4260 (1989). |
M. A. Robbie et al., "Mechanism of Resistance of Noncyclic Mammalian Cells to 4.sup.1 -(9-Acridinylamino)methanesulfon-m-anisidide: Comparison of Uptake, Metabolism, and DNA Breakage in Log-and Plateau-Phase Chinese Hamster Fibroblast Cell Cultures", Cancer Research, 48, pp. 310-319 (Jan. 15, 1988). |
P. B. Roberts et al., "Radiosensitization of Mammalian Cells in Vitro by Nitroacridines", Radiation Research, 123, pp. 153-164 (1990). |
D. A. Rowley et al., "DNA Damage by Superoxide-Generating Systems in Relation to the Mechanism of Action of the Anti-Tumour Antibiotic Adriamycin", Biochimica et Biophysica Acta, 761, pp. 86-93 (1983). |
A. C. Sartorelli, "Therapeutic Attack of Hypoxic Cells of Solid Tumors: Presidential Address", Cancer Research, 48, pp. 775-778 (Feb. 15, 1988). |
D. Siemann, "Modification of Chemotherapy by Nitroimidazoles", Int. J. Radiation Oncology Biol. Phys., vol. 10, pp. 1585-1594 (1984). |
B. G. Siim et al., "Does DNA Targeting Affect the Cytotoxicity and Cell Uptake of Basic Nitroquinoline Bioreductive Drugs?", Int. J. Radiation Oncology Biol. Phys., vol. 29, No. 2, pp. 311-315 (1994). |
W. J. Slichenmyer et al., "The Current Status of Camptothecin Analogues as Antitumor Agents", Journal of the National Cancer Institute, vol. 85, No. 4, pp. 271-291 (Feb. 17, 1993). |
P. J. Smith et al., "Modification of the radiation sensitivity of human tumour cells by a bis-benzimidazole derivative", Int. J. Radiat. Biol., vol. 46, No. 4, pp. 331-344 (1984). |
G. G. Steel et al., "Exploitable Mechanisms in Combined Radiotherapy-Chemotherapy: The Concept of Additivity", Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 85-91 (1979). |
M. R. L. Stratford et al., "Radiosensitizer-DNA Interactions in Relation to Intracelluar Uptake", Int. J. Radiation Oncology Biol. Phys., vol. 16, pp. 1007-1010 (1989). |
I. Tannock et al., "Response of Chinese Hamster Ovary Cells to Anti-Cancer Drugs Under Aerobic and Hypoxic Conditions", Br. J. Cancer, 43, p. 245 (1981). |
Y. C. Taylor et al., "Mechanism of Sensitization of Chinese Hamster Ovary Cells to Melphalan by Hypoxic Treatment with Misonidazole", Cancer Research, 43, pp. 3175-3181 (Jul. 1983). |
W. R. Wilson et al., "Reductive Metabolism and Hypoxia-Selective Toxicity of Nitracrine", Int. J. Radiation Oncology Biol. Phys., vol. 12, pp. 1235-1238 (1986). |
W. R. Wilson et al., "5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline(5-Nitraquine), a New DNA-Affinic Hypoxic Cell Radiosensitizer and Bioreductive Agent: Comparison with Nitracine", Radiation Research, 131, pp. 257-265 (1992). |
M. Yamato et al., "Synthesis and Antitumor Activity of Fused Tetracyclic Quinoline Derivatives", J. Med. Chem., 32, pp. 1295-1300 (1989). |
L. Zwelling, "DNA topoisomerase II as a target of antineoplastic drug therapy", Cancer and Metastatis Reviews 4, pp. 263-276 (1985). |